Current definition excludes ischemic, hypertensive, and valvular heart disease
IMAGING
General Features
Radiographic Findings
CT Findings
MR Findings
Echocardiographic Findings
Angiographic Findings
Nuclear Medicine Findings
Imaging Recommendations
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Staging, Grading, & Classification
Gross Pathologic & Surgical Features
Microscopic Features
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
DIAGNOSTIC CHECKLIST
Consider
Image Interpretation Pearls
Selected References
Brown PF et al: Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathy. Heart. ePub, 2018
Halliday BP et al: Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future. Circulation. 136(2):215-231, 2017
Youn JC et al: Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Eur Radiol. 27(9):3924-3933, 2017
Disertori M et al: Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis. JACC Cardiovasc Imaging. 9(9):1046-55, 2016
Rajiah P et al: Update on the role of cardiac magnetic resonance in acquired nonischemic cardiomyopathies. J Thorac Imaging. 31(6):348-66, 2016
Gulati A et al: Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 309(9):896-908, 2013
Puntmann VO et al: Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 6(4):475-84, 2013
Ismail TF et al: Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy. Heart. 98(6):438-42, 2012
Gottlieb I et al: Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives. Heart Fail Rev. 11(4):313-23, 2006
Rochitte CE et al: The emerging role of MRI in the diagnosis and management of cardiomyopathies. Curr Cardiol Rep. 8(1):44-52, 2006
Abbara S et al: Pericardial and myocardial disease. In Miller SW: Cardiac Imaging: The Requisites. 2nd ed. Philadelphia: Mosby. 270-2, 2005
Zipes DP et al: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia: Saunders/Elsevier, 2005
McCrohon JA et al: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 108(1):54-9, 2003
Felker GM et al: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 342(15):1077-84, 2000
Current definition excludes ischemic, hypertensive, and valvular heart disease
IMAGING
General Features
Radiographic Findings
CT Findings
MR Findings
Echocardiographic Findings
Angiographic Findings
Nuclear Medicine Findings
Imaging Recommendations
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Staging, Grading, & Classification
Gross Pathologic & Surgical Features
Microscopic Features
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
DIAGNOSTIC CHECKLIST
Consider
Image Interpretation Pearls
Selected References
Brown PF et al: Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathy. Heart. ePub, 2018
Halliday BP et al: Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future. Circulation. 136(2):215-231, 2017
Youn JC et al: Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Eur Radiol. 27(9):3924-3933, 2017
Disertori M et al: Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis. JACC Cardiovasc Imaging. 9(9):1046-55, 2016
Rajiah P et al: Update on the role of cardiac magnetic resonance in acquired nonischemic cardiomyopathies. J Thorac Imaging. 31(6):348-66, 2016
Gulati A et al: Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 309(9):896-908, 2013
Puntmann VO et al: Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 6(4):475-84, 2013
Ismail TF et al: Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy. Heart. 98(6):438-42, 2012
Gottlieb I et al: Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives. Heart Fail Rev. 11(4):313-23, 2006
Rochitte CE et al: The emerging role of MRI in the diagnosis and management of cardiomyopathies. Curr Cardiol Rep. 8(1):44-52, 2006
Abbara S et al: Pericardial and myocardial disease. In Miller SW: Cardiac Imaging: The Requisites. 2nd ed. Philadelphia: Mosby. 270-2, 2005
Zipes DP et al: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia: Saunders/Elsevier, 2005
McCrohon JA et al: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 108(1):54-9, 2003
Felker GM et al: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 342(15):1077-84, 2000